Compare Summit Therapeutics Inc (SMMT) vs Vistra Corp (VST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Vistra Corp — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Vistra Corp trades at $162.05 (market cap $53.27B). The key difference: Vistra Corp is far larger — about 5.1× Summit Therapeutics Inc's market cap, and Vistra Corp pays a 0.58% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | VST | |
|---|---|---|
Market Cap | $10.48B | $53.27B |
Sector | Health | Technology |
52-Week High | $29.32 | $217.92 |
52-Week Low | $13.05 | $134.71 |
Enterprise Value | $9.90B | $75.03B |
Dividend Yield | — | 0.58% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →
